Article Information
PubMed
Published By
Print ISSN
Online ISSN
History
- Received May 5, 2021
- Accepted July 30, 2021
- Published online August 26, 2021.
Article Versions
- You are currently viewing a previous version of this article (August 26, 2021 - 07:51).
- View the most recent version of this article
Copyright & Usage
Copyright ©The authors 2021. For reproduction rights and permissions contact permissions@ersnet.org
Author Information
- Mirjam P. Roffel1,2,3,
- Ilse M. Boudewijn2,4,
- Jos L.L. van Nijnatten1,2,5,
- Alen Faiz1,2,5,
- Corneel J. Vermeulen2,4,
- Antoon J. van Oosterhout6,
- Karen Affleck7,
- Wim Timens1,2,
- Ken R. Bracke3,
- Tania Maes3,
- Irene H. Heijink1,2,4,
- Corry-Anke Brandsma1,2,8 and
- Maarten van den Berge2,4,8⇑
- 1Department of Pathology and Medical Biology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands
- 2University of Groningen, University Medical Center Groningen, Groningen Research Institute for Asthma and COPD, Groningen, The Netherlands
- 3Department of Respiratory Medicine, Ghent University, University Hospital Ghent, Laboratory for Translational Research in Obstructive Pulmonary Diseases, Ghent, Belgium
- 4Department of Pulmonology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands
- 5Faculty of Science, Respiratory Bioinformatics and Molecular Biology (RBMB), University of Technology Sydney, Sydney, Australia
- 6Allergic Inflammation Discovery Performance Unit, GlaxoSmithKline, Stevenage, United Kingdom
- 7Adaptive Immunity Research Unit, GlaxoSmithKline, Stevenage, United Kingdom
- 8Both senior authors contributed equally
- Maarten van den Berge (m.van.den.berge{at}umcg.nl)
Funding
Bijzonder Onderzoeksfonds
05U40516Ministerie van Economische Zaken en Klimaat
GlaxoSmithKline